Active ingredients
Pharmacological Group
Used in the treatment of
- I50.9 Heart failure, unspecified
- I25 Chronic ischaemic heart disease
- I21 Acute myocardial infarction
- E63 Other nutritional deficiencies
- Q85.1 Tuberous sclerosis
- I42.0 Dilated cardiomyopathy
- G71.3 Mitochondrial myopathy, not elsewhere classified
- G71.2 Congenital myopathies
- G31.8 Other specified degenerative diseases of nervous system
- E61.8 Deficiency of other specified nutrient elements